Ziopharm Oncology (ZIOP) Tops Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts ZIOP Hot Sheet
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q3 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
